AllianceBernstein
CRBP icon

AllianceBernstein’s Corbus Pharmaceuticals CRBP Stock Holding History

AllianceBernstein’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,920
Closed -$205K – 3226
2024
Q3 		$205K Buy
9,920
+2,710
+38% +$139K ﹤0.01% 3037
2024
Q2 		$326K Buy
+7,210
New +$303K ﹤0.01% 2881
2021
Q2 		– Sell
-1,440
Closed -$85K – 3344
2021
Q1 		$85K Hold
1,440
– – ﹤0.01% 3171
2020
Q4 		$54K Sell
1,440
-1,503
-51% -$56.2K ﹤0.01% 3140
2020
Q3 		$159K Sell
2,943
-1,457
-33% -$264K ﹤0.01% 2996
2020
Q2 		$1.11M Buy
4,400
+17
+0.4% +$3.44K ﹤0.01% 2154
2020
Q1 		$689K Buy
4,383
+1,456
+50% +$246K ﹤0.01% 2206
2019
Q4 		$479K Hold
2,927
– – ﹤0.01% 2565
2019
Q3 		$428K Hold
2,927
– – ﹤0.01% 2633
2019
Q2 		$608K Hold
2,927
– – ﹤0.01% 2521
2019
Q1 		$610K Sell
2,927
-86
-3% -$19K ﹤0.01% 2447
2018
Q4 		$528K Buy
3,013
+1,166
+63% +$233K ﹤0.01% 2456
2018
Q3 		$418K Buy
1,847
+704
+62% +$114K ﹤0.01% 2691
2018
Q2 		$173K Buy
1,143
+216
+23% +$39.2K ﹤0.01% 2995
2018
Q1 		$170K Buy
927
+420
+83% +$94.3K ﹤0.01% 2888
2017
Q4 		$108K Buy
507
+140
+38% +$30K ﹤0.01% 2959
2017
Q3 		$79K Hold
367
– – ﹤0.01% 3058
2017
Q2 		$69K Buy
+367
New +$72K ﹤0.01% 3115

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein's CRBP Position: Q4 2024 in Review

AllianceBernstein sold out of Corbus Pharmaceuticals (CRBP) in Q4 2024, closing a stake of 9,920 shares — an estimated $205K sold.

AllianceBernstein first reported a position in CRBP in Q2 2017 and held it in 18 quarters. The position peaked at $1.11M in Q2 2020. 99 funds tracked by Wall St. Rank hold CRBP as of Q4 2024.

  • AllianceBernstein reported no remaining Corbus Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • AllianceBernstein sold 9,920 Corbus Pharmaceuticals shares in Q4 2024, an estimated $205K.
  • AllianceBernstein first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 18 quarters.
  • AllianceBernstein's Corbus Pharmaceuticals position peaked at $1.11M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2024.

Based on AllianceBernstein's 13F filing for Q4 2024, filed 12 Feb 2025.